vs
Leslie's, Inc.（LESL）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Leslie's, Inc.的1.4倍（$207.3M vs $147.1M），Leslie's, Inc.净利率更高（-56.4% vs -62.0%，领先5.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -16.0%），Leslie's, Inc.自由现金流更多（$-85.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -11.7%）
莱斯利公司（Leslie's, Inc.）主营游泳池相关用品零售，旗下运营莱斯利游泳池用品品牌，是全球规模最大的游泳池用品零售商。公司总部坐落于美国亚利桑那州凤凰城，在亚利桑那、加利福尼亚、佛罗里达、佐治亚及得克萨斯等州拥有极强的零售布局优势。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
LESL vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.1M | $207.3M |
| 净利润 | $-83.0M | $-128.6M |
| 毛利率 | 18.4% | — |
| 营业利润率 | -46.7% | -54.7% |
| 净利率 | -56.4% | -62.0% |
| 营收同比 | -16.0% | 25.9% |
| 净利润同比 | -86.2% | 3.5% |
| 每股收益（稀释后） | $-8.92 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $147.1M | — | ||
| Q4 25 | $389.2M | $207.3M | ||
| Q3 25 | — | $159.9M | ||
| Q2 25 | $500.3M | $166.5M | ||
| Q1 25 | $177.1M | $139.3M | ||
| Q4 24 | $175.2M | $164.6M | ||
| Q3 24 | $397.9M | $139.5M | ||
| Q2 24 | $569.6M | $147.0M |
| Q1 26 | $-83.0M | — | ||
| Q4 25 | $-162.8M | $-128.6M | ||
| Q3 25 | — | $-180.4M | ||
| Q2 25 | $21.7M | $-115.0M | ||
| Q1 25 | $-51.3M | $-151.1M | ||
| Q4 24 | $-44.6M | $-133.2M | ||
| Q3 24 | $-9.9M | $-133.5M | ||
| Q2 24 | $60.6M | $-131.6M |
| Q1 26 | 18.4% | — | ||
| Q4 25 | 38.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 24.8% | — | ||
| Q4 24 | 27.2% | — | ||
| Q3 24 | 36.0% | — | ||
| Q2 24 | 40.2% | — |
| Q1 26 | -46.7% | — | ||
| Q4 25 | -38.6% | -54.7% | ||
| Q3 25 | — | -106.9% | ||
| Q2 25 | 13.7% | -64.8% | ||
| Q1 25 | -27.3% | -102.6% | ||
| Q4 24 | -22.7% | -74.3% | ||
| Q3 24 | 6.6% | -94.6% | ||
| Q2 24 | 17.2% | -79.1% |
| Q1 26 | -56.4% | — | ||
| Q4 25 | -41.8% | -62.0% | ||
| Q3 25 | — | -112.8% | ||
| Q2 25 | 4.3% | -69.0% | ||
| Q1 25 | -29.0% | -108.5% | ||
| Q4 24 | -25.4% | -80.9% | ||
| Q3 24 | -2.5% | -95.7% | ||
| Q2 24 | 10.6% | -89.5% |
| Q1 26 | $-8.92 | — | ||
| Q4 25 | $-20.59 | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | $0.12 | $-1.17 | ||
| Q1 25 | $-0.28 | $-1.57 | ||
| Q4 24 | $-4.82 | $-1.34 | ||
| Q3 24 | $-2.46 | $-1.40 | ||
| Q2 24 | $0.33 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.6M | $421.0M |
| 总债务越低越好 | $781.6M | — |
| 股东权益账面价值 | $-489.9M | $-80.0M |
| 总资产 | $649.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $3.6M | — | ||
| Q4 25 | $64.3M | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | $42.7M | $176.3M | ||
| Q1 25 | $17.3M | $127.1M | ||
| Q4 24 | $11.6M | $174.0M | ||
| Q3 24 | $108.5M | $150.6M | ||
| Q2 24 | $74.4M | $480.7M |
| Q1 26 | $781.6M | — | ||
| Q4 25 | $756.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $776.6M | — | ||
| Q1 25 | $858.1M | — | ||
| Q4 24 | $796.6M | — | ||
| Q3 24 | $783.7M | — | ||
| Q2 24 | $783.7M | — |
| Q1 26 | $-489.9M | — | ||
| Q4 25 | $-408.0M | $-80.0M | ||
| Q3 25 | — | $9.2M | ||
| Q2 25 | $-246.2M | $151.3M | ||
| Q1 25 | $-269.5M | $144.2M | ||
| Q4 24 | $-220.0M | $255.0M | ||
| Q3 24 | $-177.1M | $346.8M | ||
| Q2 24 | $-168.2M | $432.4M |
| Q1 26 | $649.4M | — | ||
| Q4 25 | $741.5M | $1.5B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $989.5M | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $967.0M | $1.5B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.1B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-81.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-85.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | -58.1% | -48.6% |
| 资本支出强度资本支出/营收 | 2.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $7.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | $-81.1M | — | ||
| Q4 25 | $48.2M | $-99.8M | ||
| Q3 25 | — | $-91.4M | ||
| Q2 25 | $114.9M | $-108.3M | ||
| Q1 25 | $-49.2M | $-166.5M | ||
| Q4 24 | $-105.1M | $-79.3M | ||
| Q3 24 | $47.1M | $-67.0M | ||
| Q2 24 | $175.5M | $-77.0M |
| Q1 26 | $-85.5M | — | ||
| Q4 25 | $41.8M | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | $107.1M | $-110.7M | ||
| Q1 25 | $-55.8M | $-167.8M | ||
| Q4 24 | $-109.8M | $-79.5M | ||
| Q3 24 | $34.1M | $-68.6M | ||
| Q2 24 | $165.2M | $-79.0M |
| Q1 26 | -58.1% | — | ||
| Q4 25 | 10.7% | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | 21.4% | -66.5% | ||
| Q1 25 | -31.5% | -120.5% | ||
| Q4 24 | -62.6% | -48.3% | ||
| Q3 24 | 8.6% | -49.2% | ||
| Q2 24 | 29.0% | -53.7% |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 1.7% | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | 1.6% | 1.5% | ||
| Q1 25 | 3.7% | 1.0% | ||
| Q4 24 | 2.7% | 0.1% | ||
| Q3 24 | 3.2% | 1.2% | ||
| Q2 24 | 1.8% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.29× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LESL
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
